尤物视频污,99热99热99超碰,精品久久久久女少妇,少妇精品无码,日B视屏久久香色,亚洲美女午夜福利av,国产美女被操,国产九九精品,国产久久色情

Tianchi Pharmaceutical Co., Ltd. was founded in 2011 and is a national high-tech enterprise invested by natural persons, venture capital funds, and state-owned companies. It holds 10 national invention patents with independent intellectual property rights and 8 scientific and technological achievements. The company has established the Henan Provincial Engineering Technology Research Center for Chiral Chemical New Materials and is a key enterprise in Henan Province designated for future listing. The company operates three modern production bases across two locations: Puyang Tianjian Biotechnology, Tianchi (Puyang) New Materials, and Tianchi (Anyang) New Materials.

As the initial base of Tianchi Pharmaceutical, Puyang Tianjian Biotechnology Co., Ltd. has defined its development direction as an innovative and green fine chemical enterprise. It continuously advances in the fields of advanced pharmaceutical intermediates, chiral resolving agents, electronic and polymer new materials, and maintains close cooperation with several multinational chemical giants, creating sustainable development and value for relevant stakeholders in the industry. The enterprise generates an annual profit and tax revenue of over 20 million yuan. Pursuing excellence, quality, core competitiveness, and social responsibility, the company adheres to the corporate mission of "benefiting humanity through technology and innovation" and looks forward to sincere cooperation with domestic and international clients to achieve mutual success.

Today, Tianchi Pharmaceutical has established close partnerships with outstanding universities, research institutions, and industry leaders both domestically and internationally. It is diligently working towards the development of various細(xì)分 products in the three major categories of pharmaceuticals, pesticides, and new materials, striving to become one of the top 100 chemical enterprises in China.

In the future, Tianchi Pharmaceutical will continue to adhere to a strategy of modernization, intelligence, and serialization. Guided by market demand and driven by technological innovation, the company will persistently leverage its advantages to conduct in-depth research and development in前瞻性 fields and application areas. It will continuously explore the future of chemistry and new materials, strengthen its advantages, and strive to become a leader in the industry.